The present invention relates to therapeutically active novel aminoindanes of formula (I). Also provided is a method of preparing compounds of formula (I), and pharmaceutical compositions comprising the compounds. The novel compounds act as modulators of metabotropic glutamate receptors and, as such, are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
本发明涉及公式(I)的治疗活性新型
氨基
茚烷。还提供了制备公式(I)化合物的方法,以及包含该化合物的制药组合物。这些新型化合物作为代谢型谷
氨酸受体的调节剂,因此在治疗与代谢型谷
氨酸受体系统有关的中枢神经系统疾病方面是有用的。